Respirology

Pfizer’s Paxlovid expected to overshadow Merck’s molnupiravir, with higher efficacy in preventing hospitalization/death in high-risk outpatients with mild/moderate COVID-19.

Study investigates the incidence of false-positives in a large sample of SARS-CoV-2 rapid antigen tests used to screen asymptomatic workers throughout Canada.

Guideline update: Diagnosis and management of asthma in preschoolers, children and adults.

But vaccination still offers protection, study finds

Canadian review highlights recommended investigations, current management options and new treatments under study for chronic cough

Study finds a 64% relative reduction in the risk for death, and one life saved for every 400 patients enrolled in the remote monitoring service.

Here are three research papers that caught our eye this week.

Studies for Spikevax for kids even younger are ongoing.